{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:47:01Z","timestamp":1761630421422,"version":"3.40.5"},"reference-count":33,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,9,1]]},"abstract":"<jats:p>BACKGROUND. Allogeneic organ transplantation has become a common procedure in acute and chronic organ failure. The major limitation, rejection of the allograft by the host's immune system, can be limited by various immunosuppressive drugs that target the adaptive T-cell response. Most of these drugs are used in the treatment of allergic diseases as well, suggesting that transplant recipients under long-term immunosuppressive therapy should not develop any sensitizations or at least not show any clinical signs of allergy. Surprisingly, organ-transplanted children and adults do report symptoms of type 1 allergies, such as allergic rhinoconjunctivitis, bronchial asthma, and food allergies. Thus far, mainly case reports and series on the occurrence of allergy after orthotopic liver transplantation exist.<\/jats:p>\n               <jats:p>OBJECTIVE. Our purpose with this study was to evaluate in a cross-sectional design the prevalence of immunoglobulin E-mediated sensitizations and type 1 allergies in solid organ\u2013transplanted children and adolescents and to identify risk factors.<\/jats:p>\n               <jats:p>METHODS. Seventy-eight organ-transplanted subjects (50 kidney, 9 lung, 19 liver; mean age: 14.06 \u00b1 5.94 years; range 1.42 to 24.25 years) were studied by standardized interviews (modified International Study of Asthma and Allergies in Childhood [ISAAC] criteria), skin-prick tests, and measurement of specific and total serum immunoglobulin E.<\/jats:p>\n               <jats:p>RESULTS. Nineteen patients (24.4%) were found to be sensitized to \u22651 common inhalant or food allergens, as reflected by elevated specific immunoglobulin E levels and\/or positive skin-prick test results, and 8 subjects (10.3%) additionally reported a corresponding present history of atopic diseases. No severe anaphylactic reactions were reported. No statistically significant associations with gender, kind of transplanted organ, distinct immunosuppressive therapies, and age at time of transplantation or age at investigation were found (\u03c72 test, Fisher's exact test, and Wilcoxon rank-sum test, respectively). Multiple logistic-regression analysis did not identify any independent risk factor either.<\/jats:p>\n               <jats:p>CONCLUSION. This study demonstrates that therapeutic immunosuppression does not control sensitizations and clinical manifestation of type 1 allergies in organ-transplanted children and adolescents.<\/jats:p>","DOI":"10.1542\/peds.2006-0370","type":"journal-article","created":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T21:17:38Z","timestamp":1157145458000},"page":"e764-e770","source":"Crossref","is-referenced-by-count":24,"title":["Immunosuppressive Therapy Does Not Prevent the Occurrence of Immunoglobulin E\u2013Mediated Allergies in Children and Adolescents With Organ Transplants"],"prefix":"10.1542","volume":"118","author":[{"given":"Eleonora","family":"Dehlink","sequence":"first","affiliation":[{"name":"Departments of Pediatrics and Adolescent Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saskia","family":"Gruber","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics and Adolescent Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Eiwegger","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics and Adolescent Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Gruber","sequence":"additional","affiliation":[{"name":"Cardiothoracic Surgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Mueller","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics and Adolescent Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolf-Dietrich","family":"Huber","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics and Adolescent Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Klepetko","sequence":"additional","affiliation":[{"name":"Section of Statistics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helmut","family":"Rumpold","sequence":"additional","affiliation":[{"name":"Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Vienna, Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radvan","family":"Urbanek","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics and Adolescent Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zsolt","family":"Sze\u0301pfalusi","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics and Adolescent Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2006,9,1]]},"reference":[{"key":"2021120822524458900_R1","doi-asserted-by":"crossref","unstructured":"Gottesdiener KM. Transplanted infections: donor-to-host transmission with the allograft. Ann Intern Med.\u20081989;110:1001\u20131016","DOI":"10.7326\/0003-4819-110-12-1001"},{"key":"2021120822524458900_R2","unstructured":"Penn I. De novo malignances in pediatric organ transplant recipients. Pediatr Transplant.\u20081998;2:56\u201363"},{"key":"2021120822524458900_R3","doi-asserted-by":"crossref","unstructured":"Kelly DA. Optimal immunosuppression in teenagers. Pediatr Transplant.\u20082002;6:480\u2013487","DOI":"10.1034\/j.1399-3046.2002.01090.x"},{"key":"2021120822524458900_R4","doi-asserted-by":"crossref","unstructured":"Arikan C, Kilic M, Tokat Y, Aydogdu S. Allergic disease after pediatric liver transplantation with systemic tacrolimus and cyclosporine A therapy. Transplant Proc.\u20082003;35:3039\u20133041","DOI":"10.1016\/j.transproceed.2003.10.033"},{"key":"2021120822524458900_R5","doi-asserted-by":"crossref","unstructured":"Boyle R, Hardikar W, Tang M. The development of food allergy after liver transplantation. Liver Transpl.\u20082005;11:326\u2013330","DOI":"10.1002\/lt.20368"},{"key":"2021120822524458900_R6","doi-asserted-by":"crossref","unstructured":"Chehade M, Nowak-Wegrzyn A, Kaufman S, Fishbein T, Tschernia A, LeLeiko N. De novo food allergy after intestinal transplantation: a report of three cases. J Pediatr Gastroenterol Nutr.\u20082004;38:545\u2013547","DOI":"10.1097\/00005176-200405000-00017"},{"key":"2021120822524458900_R7","doi-asserted-by":"crossref","unstructured":"Gennery AR, Cant AJ. Development of allergy post-bone marrow transplantation. Clin Exp Allergy.\u20082002;32:1677\u20131678","DOI":"10.1046\/j.1365-2222.2002.01565.x"},{"key":"2021120822524458900_R8","doi-asserted-by":"crossref","unstructured":"Lacaille F, Laurent J, Bousquet J. Life-threatening food allergy in a child treated with FK506. J Pediatr Gastroenterol Nutr.\u20081997;25:228\u2013229","DOI":"10.1097\/00005176-199708000-00019"},{"key":"2021120822524458900_R9","doi-asserted-by":"crossref","unstructured":"Legendre C, Caillat-Zucman S, Samuel D, et al. Transfer of symptomatic peanut allergy to the recipient of a combined liver-and-kidney transplant. N Engl J Med.\u20081997;337:822\u2013824","DOI":"10.1056\/NEJM199709183371204"},{"key":"2021120822524458900_R10","doi-asserted-by":"crossref","unstructured":"Nowak-Wegrzyn A, Sicherer S, Conover-Walker M, Wood R. Food allergy after pediatric organ transplantation with tacrolimus immunosuppression. J Allergy Clin Immunol.\u20082001;108:146\u2013147","DOI":"10.1067\/mai.2001.116571"},{"key":"2021120822524458900_R11","doi-asserted-by":"crossref","unstructured":"Phan T, Strasser S, Koorey D, et al. Passive transfer of nut allergy after liver transplantation. Arch Intern Med.\u20082003;163:237\u2013239","DOI":"10.1001\/archinte.163.2.237"},{"key":"2021120822524458900_R12","doi-asserted-by":"crossref","unstructured":"Rietz H, Plummer A, Gal A. Asthma as a consequence of bone marrow transplantation. Chest.\u20082002;122:369\u2013370","DOI":"10.1378\/chest.122.1.369"},{"key":"2021120822524458900_R13","doi-asserted-by":"crossref","unstructured":"Trotter JF, Everson GT, Bock SA, Wachs M, Bak T, Kam I. Transference of peanut allergy through liver transplantation. Liver Transpl.\u20082001;7:1088\u20131089","DOI":"10.1053\/jlts.2001.29351"},{"key":"2021120822524458900_R14","doi-asserted-by":"crossref","unstructured":"Lykavieris P, Frauger E, Habes D, Bernard O, Debray D. Angioedema in pediatric liver transplant recipients under tacrolimus immunosuppression. Transplantation.\u20082003;75:152\u2013155","DOI":"10.1097\/00007890-200301150-00027"},{"key":"2021120822524458900_R15","doi-asserted-by":"crossref","unstructured":"Pacifico L, Frediani T, Simonetti A, Chiesa C, Cucchiara S. Tacrolimus and food allergy. Transplantation.\u20082003;76:1778","DOI":"10.1097\/01.TP.0000092493.58371.D6"},{"key":"2021120822524458900_R16","doi-asserted-by":"crossref","unstructured":"Lechler R, Sykes M, Thomson A, Turka L. Organ-transplantation: how much of the promise has been realized?Nat Med.\u20082005;11:605\u2013613","DOI":"10.1038\/nm1251"},{"key":"2021120822524458900_R17","doi-asserted-by":"crossref","unstructured":"Umetsu D, DeKruyff R. Th1 and Th2 CD4+ cells in the pathogenesis of allergic diseases. Proc Soc Exp Biol Med.\u20081997;215:11\u201320","DOI":"10.3181\/00379727-215-44109"},{"key":"2021120822524458900_R18","doi-asserted-by":"crossref","unstructured":"Berth-Jones J, Graham-Brown RA, Marks R, et al. Long-term efficacy and safety of cyclosporin in severe adult atopic dermatitis. Br J Dermatol.\u20081997;136:76\u201381","DOI":"10.1111\/j.1365-2133.1997.tb08750.x"},{"key":"2021120822524458900_R19","doi-asserted-by":"crossref","unstructured":"Berth-Jones J, Takwale A, Tan E, et al. Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial. Br J Dermatol.\u20082002;147:324\u2013330","DOI":"10.1046\/j.1365-2133.2002.04989.x"},{"key":"2021120822524458900_R20","unstructured":"Grundmann-Kollmann M, Podda M, Ochsendorf F, Boehncke WH, Kaufmann R, Zollner TM. Mycophenolate mofetil is effective in the treatment of atopic dermatitis. Arch Dermatol.\u20082001;137:870\u2013873"},{"key":"2021120822524458900_R21","doi-asserted-by":"crossref","unstructured":"Hanifin JM, Cooper KD, Ho VC, et al. Guidelines of care for atopic dermatitis [published correction appears in J Am Acad Dermatol. 2005;52:156]. J Am Acad Dermatol.\u20082004;50:391\u2013404","DOI":"10.1016\/j.jaad.2003.08.003"},{"key":"2021120822524458900_R22","doi-asserted-by":"crossref","unstructured":"Neuber K, Schwartz I, Itschert G, Dieck AT. Treatment of atopic eczema with oral mycophenolate mofetil. Br J Dermatol.\u20082000;143:385\u2013391","DOI":"10.1046\/j.1365-2133.2000.03667.x"},{"key":"2021120822524458900_R23","doi-asserted-by":"crossref","unstructured":"Nizankowska E, Soja J, Pinis G, et al. Treatment of steroid-dependent bronchial asthma with cyclosporin. Eur Respir J.\u20081995;8:1091\u20131099","DOI":"10.1183\/09031936.95.08071091"},{"key":"2021120822524458900_R24","doi-asserted-by":"crossref","unstructured":"Sihra BS, Kon OM, Durham SR, Walker S, Barnes NC, Kay AB. Effect of cyclosporin A on the allergen-induced late asthmatic reaction. Thorax.\u20081997;52:447\u2013452","DOI":"10.1136\/thx.52.5.447"},{"key":"2021120822524458900_R25","doi-asserted-by":"crossref","unstructured":"Sowden JM, Berth-Jones J, Ross JS, et al. Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis. Lancet.\u20081991;338:137\u2013140","DOI":"10.1016\/0140-6736(91)90134-B"},{"key":"2021120822524458900_R26","doi-asserted-by":"crossref","unstructured":"Asher MI, Keil U, Anderson HR, et al. International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J.\u20081995;8:483\u2013491","DOI":"10.1183\/09031936.95.08030483"},{"key":"2021120822524458900_R27","doi-asserted-by":"crossref","unstructured":"Kjellman N, Johansson S, Roth A. Serum IgE levels in healthy children quantified by a sandwich technique (PRIST). Clin Allergy.\u20081976;6:51\u201359","DOI":"10.1111\/j.1365-2222.1976.tb01411.x"},{"key":"2021120822524458900_R28","doi-asserted-by":"crossref","unstructured":"Position paper: allergen standardization and skin tests. The European Academy of Allergology and Clinical Immunology. Allergy. 1993;48(14 suppl):48\u201382","DOI":"10.1111\/j.1398-9995.1993.tb04762.x"},{"key":"2021120822524458900_R29","doi-asserted-by":"crossref","unstructured":"Mortz CG, Lauritsen JM, Andersen KE, Bindslev-Jensen C. Type I sensitization in adolescents: prevalence and association with atopic dermatitis. The Odense Adolescence Cohort Study on atopic diseases and dermatitis (TOACS). Acta Derm Venerol.\u20082003;83:194\u2013201","DOI":"10.1080\/00015550310007201"},{"key":"2021120822524458900_R30","doi-asserted-by":"crossref","unstructured":"Weiland SK, von Mutius E, Hirsch T, et al. Prevalence of respiratory and atopic disorders among children in the East and West of Germany five years after unification. Eur Respir J.\u20081999;14:862\u2013870","DOI":"10.1034\/j.1399-3003.1999.14d23.x"},{"key":"2021120822524458900_R31","doi-asserted-by":"crossref","unstructured":"Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet. 1998;351:1225\u20131232","DOI":"10.1016\/S0140-6736(97)07302-9"},{"key":"2021120822524458900_R32","doi-asserted-by":"crossref","unstructured":"Gabe SM, Bjarnason I, Tolou-Ghamari Z, et al. The effect of tacrolimus (FK 506) on intestinal barrier function and cellular energy production in humans. Gastroenterology.\u20081998;115:67\u201374","DOI":"10.1016\/S0016-5085(98)70366-X"},{"key":"2021120822524458900_R33","doi-asserted-by":"crossref","unstructured":"Kawamura N, Furuta H, Tame A, et al. Extremely high serum level of IgE during immunosuppressive therapy: paradoxical effect of cyclosporine A and tacrolimus. Int Arch Allergy Immunol.\u20081997;112:422\u2013424","DOI":"10.1159\/000237491"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/118\/3\/e764\/1073541\/zpe0090600e764.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/118\/3\/e764\/1073541\/zpe0090600e764.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T02:46:14Z","timestamp":1639017974000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/118\/3\/e764\/69279\/Immunosuppressive-Therapy-Does-Not-Prevent-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9,1]]},"references-count":33,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2006,9,1]]},"published-print":{"date-parts":[[2006,9,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2006-0370","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"type":"print","value":"0031-4005"},{"type":"electronic","value":"1098-4275"}],"subject":[],"published":{"date-parts":[[2006,9,1]]}}}